PHIO PHARMACEUTICALS CORP reports a Return on Equity (ROE) of -66.41%.

What is PHIO's dividend yield?

PHIO PHARMACEUTICALS CORP offers a dividend yield of 0.00%.

What is PHIO's Quality Score?

Our AI rates PHIO's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy PHIO?

Our AI Timing Score for PHIO is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does PHIO belong to?

PHIO PHARMACEUTICALS CORP is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

PHIO (NASDAQ) Stock Analysis | PHIO PHARMACEUTICALS CORP

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

PHIO AI Analysis Summary

Our AI summary for PHIO: PHIO PHARMACEUTICALS CORP (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -66.41%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

PHIO

PHIO PHARMACEUTICALS CORP

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 1.03

-0.01 (-0.49%) Day Change

Watchlist Portfolio Compare Chart

0.06

D/E

-66.4%

ROE

-62.8%

ROA

0.00%

Div Yield

PHIO PHARMACEUTICALS CORP
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 1.03 Price -0.01 (-0.49%) Day Change	NEWS SCORE: 99

PHIO, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.03
PBV / Sector	0.73 / 5.20 GREAT
Earning Per Share	-0.94

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	1.39 M GREAT
Average 1W Daily Value	0.10 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.71
NPM Average (%) / Sector	N/A / -1,721.76
NPM Change Average (%) / Sector	N/A / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-62.78 / 27.02
ROA Average (%) / Sector	-86.34 / -368.17
ROA Change Average (%) / Sector	6.60 / 5,404.12
ROE (%) / Sector	-66.41 / 3.47
ROE Average (%) / Sector	-101.06 / 6.51
ROE Change Average (%) / Sector	6.18 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 08:00:19
Symbol	PHIO
Name	PHIO PHARMACEUTICALS CORP
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	11.62 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	11.97 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 411 Swedeland Road, King of Prussia, PA, United States, 19406

Phone: 610 947 0251

Website: https://phiopharma.com

Sector: Healthcare >> Biotechnology

Description: Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.